Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.49

-0.47

-0.44

-0.42

Details

Expected EPS

-0.472

Actual EPS

-0.43

Surprise EPS

0.04

Surprise Percent

+8.9%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.43 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.